Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mixed Chinese Herbal Formula in Atopic Dermatitis
NCT05455060Phase 3Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Dec 2022
- Primary completion
- Jul 2025
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) (2 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoints: SCORing Atopic Dermatitis at 12 weeks, Dermatology Life Quality Index / Children's Dermatology Life Quality Index at 12 weeks and 1 more. Status: unknown.
02
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05455060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05455060.